Rowlandmiller & Partners’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-716
| Closed | -$105K | – | 188 |
|
|
2025
Q1 | $105K | Hold |
716
| – | – | 0.02% | 182 |
|
|
2024
Q4 | $116K | Hold |
716
| – | – | 0.02% | 173 |
|
|
2024
Q3 | $117K | Buy |
+716
| New | +$106K | 0.02% | 175 |
|
|
2024
Q2 | – | Sell |
-716
| Closed | -$110K | – | 179 |
|
|
2024
Q1 | $110K | Hold |
716
| – | – | 0.02% | 176 |
|
|
2023
Q4 | $102K | Buy |
+716
| New | +$95.5K | 0.02% | 176 |
|
|
2023
Q3 | – | Sell |
-716
| Closed | -$114K | – | 175 |
|
|
2023
Q2 | $114K | Hold |
716
| – | – | 0.03% | 172 |
|
|
2023
Q1 | $113K | Hold |
716
| – | – | 0.03% | 170 |
|
|
2022
Q4 | $102K | Buy |
+716
| New | +$102K | 0.03% | 177 |
|
|
2022
Q3 | – | Sell |
-716
| Closed | -$101K | – | 173 |
|
|
2022
Q2 | $101K | Buy |
+716
| New | +$102K | 0.03% | 173 |
|
|
2022
Q1 | – | Sell |
-716
| Closed | -$125K | – | 189 |
|
|
2021
Q4 | $125K | Sell |
716
-1,628
| -69% | -$271K | 0.03% | 170 |
|
|
2021
Q3 | $514K | Buy |
2,344
+1,578
| +206% | +$272K | 0.17% | 77 |
|
|
2021
Q2 | $138K | Sell |
766
-175
| -19% | -$31.9K | 0.03% | 157 |
|
|
2021
Q1 | $182K | Hold |
941
| – | – | 0.05% | 141 |
|
|
2020
Q4 | $190K | Sell |
941
-1,521
| -62% | -$315K | 0.05% | 135 |
|
|
2020
Q3 | $427K | Buy |
2,462
+118
| +5% | +$26.3K | 0.17% | 79 |
|
|
2020
Q2 | $514K | Sell |
2,344
-118
| -5% | -$23.6K | 0.17% | 77 |
|
|
2020
Q1 | $427K | Buy |
2,462
+9
| +0.4% | +$1.49K | 0.17% | 79 |
|
|
2019
Q4 | $377K | Buy |
2,453
+289
| +13% | +$43.2K | 0.12% | 91 |
|
|
2019
Q3 | $328K | Buy |
2,164
+9
| +0.4% | +$1.42K | 0.11% | 93 |
|
|
2019
Q2 | $329K | Sell |
2,155
-164
| -7% | -$25.1K | 0.11% | 93 |
|
|
2019
Q1 | $372K | Sell |
2,319
-59
| -2% | -$9.15K | 0.13% | 90 |
|
|
2018
Q4 | $367K | Sell |
2,378
-820
| -26% | -$128K | 0.15% | 85 |
|
|
2018
Q3 | $481K | Buy |
3,198
+9
| +0.3% | +$1.28K | 0.17% | 81 |
|
|
2018
Q2 | $431K | Buy |
3,189
+10
| +0.3% | +$1.23K | 0.17% | 80 |
|
|
2018
Q1 | $423K | Buy |
3,179
+9
| +0.3% | +$1.21K | 0.17% | 78 |
|
|
2017
Q4 | $472K | Buy |
3,170
+11
| +0.3% | +$1.5K | 0.19% | 75 |
|
|
2017
Q3 | $414K | Sell |
3,159
-547
| -15% | -$73.5K | 0.17% | 76 |
|
|
2017
Q2 | $495K | Sell |
3,706
-153
| -4% | -$20.6K | 0.21% | 71 |
|
|
2017
Q1 | $521K | Sell |
3,859
-28
| -0.7% | -$3.63K | 0.23% | 67 |
|
|
2016
Q4 | $466K | Buy |
3,887
+16
| +0.4% | +$1.89K | 0.21% | 65 |
|
|
2016
Q3 | $485K | Buy |
3,871
+14
| +0.4% | +$1.83K | 0.22% | 63 |
|
|
2016
Q2 | $533K | Sell |
3,857
-29
| -0.7% | -$3.76K | 0.25% | 64 |
|
|
2016
Q1 | $490K | Sell |
3,886
-200
| -5% | -$25.4K | 0.23% | 66 |
|
|
2015
Q4 | $509K | Sell |
4,086
-35
| -0.8% | -$4.34K | 0.26% | 63 |
|
|
2015
Q3 | $474K | Sell |
4,121
-1,019
| -20% | -$114K | 0.25% | 65 |
|
|
2015
Q2 | $535K | Sell |
5,140
-3,342
| -39% | -$361K | 0.27% | 64 |
|
|
2015
Q1 | $932K | Sell |
8,482
-2,596
| -23% | -$282K | 0.46% | 53 |
|
|
2014
Q4 | $1.15M | Buy |
+11,078
| New | +$1.11M | 0.56% | 49 |
|
Other funds holding CLX
Rowlandmiller & Partners's CLX Position: Q2 2025 in Review
Rowlandmiller & Partners sold out of Clorox (CLX) in Q2 2025, closing a stake of 716 shares — an estimated $105K sold.
Rowlandmiller & Partners first reported a position in CLX in Q4 2014 and held it in 38 quarters. The position peaked at $1.15M in Q4 2014. 1,126 funds tracked by Wall St. Rank hold CLX as of Q2 2025.
- Rowlandmiller & Partners reported no remaining Clorox position as of Q2 2025 after selling out during the quarter.
- Rowlandmiller & Partners sold 716 Clorox shares in Q2 2025, an estimated $105K.
- Rowlandmiller & Partners first reported a position in Clorox in Q4 2014 and held it in 38 quarters.
- Rowlandmiller & Partners's Clorox position peaked at $1.15M in Q4 2014.
- 1,126 funds tracked by Wall St. Rank held Clorox as of Q2 2025.
Based on Rowlandmiller & Partners's 13F filing for Q2 2025, filed 1 Jul 2025.